The document discusses the rising costs of unreimbursed pharmaceutical expenses for hospitals and the role that patient assistance programs play in helping to offset some of those costs, but notes that managing these programs can present organizational challenges for hospitals. It then describes how Rx Review acts as a resource for hospitals by handling the administration of patient assistance programs in order to help lower hospitals' unreimbursed drug costs without requiring additional hiring or straining existing hospital staff and resources.